Logo
H

HotSpot Therapeutics, Inc.

66 employees

Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new ways. Unlike conventional drug discovery, which focuses on targeting the active sites of proteins, HotSpot has developed a technology platform to uncover nature’s privileged regulatory hotspots – pockets remote from the active site that are critical to protein function. Our team is designing novel therapies directed at regulatory hotspots, allowing us to treat diseases with limited or no known treatment options. Hotspot medicines are superior to conventional therapeutics given their exquisite selectivity, potent in vivo pharmacology and attractive drug-like properties.

Investor insights

Funding rounds participated in

$100M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2017

Funding rounds raised

Total raised

$100M

from 2 investors over 1 rounds

H

HotSpot Therapeutics, Inc. raised $100M on December 29, 2021

Investors: Pivotal bioVenture Partners and + 8 Other investors

FAQ